Cargando…
CYP450 drug inducibility in NAFLD via an in vitro hepatic model: Understanding drug-drug interactions in the fatty liver
Drug-drug-interactions (DDIs) occur when a drug alters the metabolic rate, efficacy, and toxicity of concurrently used drugs. While almost 1 in 4 adults now use at least 3 concurrent prescription drugs in the United States, the Non-alcoholic fatty liver disease (NAFLD) prevalence has also risen over...
Autores principales: | Rey-Bedon, Camilo, Banik, Peony, Gokaltun, Aslihan, Hofheinz, O., Yarmush, Martin. L., Uygun, M. Korkut, Usta, O. Berk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792443/ https://www.ncbi.nlm.nih.gov/pubmed/35062050 http://dx.doi.org/10.1016/j.biopha.2021.112377 |
Ejemplares similares
-
Rapid maturation of the hepatic cell line Huh7 via CDK inhibition for PXR dependent CYP450 metabolism and induction
por: Bulutoglu, Beyza, et al.
Publicado: (2019) -
A comparison of hepato-cellular in vitro platforms to study CYP3A4 induction
por: Bulutoglu, Beyza, et al.
Publicado: (2020) -
Simple Surface Modification of Poly(dimethylsiloxane) via Surface Segregating Smart Polymers for Biomicrofluidics
por: Gökaltun, Aslıhan, et al.
Publicado: (2019) -
Alterations in Cytoskeleton and Mitochondria in the Development and Reversal of Steatosis in Human Hepatocytes
por: Fan, Letao, et al.
Publicado: (2023) -
Drug-drug interactions: it is not only CYP450's which matter
por: Back, David J
Publicado: (2010)